Canaccord Genuity Maintains Buy on Stryker, Lowers Price Target to $385
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice TargetHot
Canaccord Genuity analyst Kyle Rose maintains Stryker (NYSE:SYK) with a Buy and lowers the price target from $400 to $385.
Canaccord Genuity analyst Kyle Rose maintains Stryker (NYSE:SYK) with a Buy and lowers the price target from $400 to $385.